Tuberculosis and respiratory infections remain among the leading causes of illness and mortality worldwide. Continued research and improved healthcare strategies are essential for effective prevention, diagnosis, and treatment.
This session focuses on tuberculosis, pneumonia, influenza, COVID-19, and other respiratory infections. Discussions will highlight advances in diagnostics, treatment protocols, vaccination, and public health interventions.
Attendees will explore current clinical guidelines, emerging therapies, and global initiatives focused on reducing the burden of respiratory infectious diseases.